Vassilios Katsos – CEO Pharmathen Global BV

Vassilio_KatsosMr. Vassilios Katsos was born in Athens. He graduated from Pierce College and continued his studies at the University of Athens at the School of Pharmacy. In 1993 as one of the major shareholders, he assumed the position of President of the Board of Directors at Pharmathen S.A. Under his leadership, the strategic restructuring of the family company began in 1993, placing emphasis first on strengthening the company’s presence in the Greek market and thereafter on the expansion of international activities. Mr. Katsos, as member of the Board of Directors, recently assumed the role of CEO of Pharmathen Global BV, based in the Netherlands.


Nelly Katsou - President of the Board of Directors & CEO of Pharmathen SA & Greek entities

Nellie_KatsouMrs. Nelly Katsou was born in Athens and holds a BSc degree from the University of Athens - School of Pharmacy. She is a major shareholder and has been a leading member of the administration of Pharmathen since 1993. Along with Mr. Vassilios Katsos, she envisioned and methodically worked to bring Pharmathen to a prominent position in the global pharmaceutical industry. Today, Mrs. Katsou is the President of the Board of Directors & CEO of Pharmathen SA and Greek entities.


Dimitris Kadis – Deputy CEO

Dimitris_KadisMr. Dimitris Kadis is an experienced business executive who has been working at Pharmathen since 2003. He holds an MBA from the Warwick Business School and a BSc in Economics from the University of Athens. During his career, he has held senior roles with an experience spanning financial analysis, corporate and business development, strategic planning, general management and operations. Mr. Kadis currently holds the position of Deputy CEO.

Dr. Evangelos Karavas – Vice-President of the Board of Directors & Chief Scientific Officer

Evaggelos_KaravasDr. Evangelos Karavas graduated from the School of Chemistry and acquired his PhD in Pharmaceutical Technology at the Aristotle University of Thessaloniki. Having worked at Pharmathen since 1991 in several senior roles in R&D and Production, Dr. Karavas has been responsible since 2003 for all the Industrial and Research activities of the Group as Vice-President of Research & Industrial operations until recently that he has been appointed Vice-President of the Board of Directors and Chief Scientific Officer.

Diomedes Vassiliou – Group Chief Financial Officer

Mr. Diomedes Vassiliou is the CFO of Pharmathen Group. Mr. Vassiliou holds a BSc degree in Accounting and Finance from London School of Economics, where he was a Chevening Scholar. He is a qualified Fellow Chartered Accountant member of ICAEW and CPA fellow member of ICPAC. He has extensive experience in the finance and advisory sectors. Prior to joining Pharmathen, Mr. Vassiliou served as Group CFO at Intralot, Antenna and Regency Entertainment. Furthermore, he has held senior financial positions in large multinational corporations throughout South Eastern Europe, including at Hellenic Petroleum and AIG - ALICO and has also worked for PwC (Greece) and Ernst & Young (London).